De novo expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 11, Issue 11, 1996, Pages 2155-2162

  Gogusev, J ^a   Duchambon, P ^a   Stoermann Chopard, C ^a   Giovannini, M ^a   Sarfati, E ^b   Drueke T B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Growth factors; Hyperparathyroidism; Primary; PTH; Secondary; Uraemia

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IN SITU HYBRIDIZATION; MALE; PARATHYROID GLAND; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0029910443     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027131     Document Type: Article

References (30)

1. Silver J, Moallem E, Epstein E, Kilav R, Naveh-Many T. New aspects in the control of parathyroid hormone secretion. Curr Opin Nephrol Hypertens 1994; 3: 379-385
2. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 1988; 318: 658-662
3. Arnold A, Kim HG, Gaz RD et al Molecular cloning and chromosome mapping of DNA rearranged with the parathyroid hormone gene in parathyroid adenoma. J Clin Invest 1989; 83: 2034-2040
4. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 1996; 56: 599-605
5. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-2054
6. Tominaga Y, Kohara S, Namii Y et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996; in press
7. Cryns VL, Thor A, Xu HJ et al. Loss of retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 1994; 330: 757-761
8. Cryns VL, Rubio MP, Thor AD, Louis DN, Arnold A. p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 1320-1324
9. Mulligan LM, Kwok JBJ, Healy CS. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460
10. Duh QY, Gum ET, Joan MS et al. Epidermal growth factor receptors in parathyroid tumors. J Surg Res 1986; 40: 569-573
11. Aasland R, Akslen LA, Varghaug JE, Lillehaug JR. Co-expression of the genes encoding transforming growth factor-α and its receptor in papillary carcinomas of the thyroid. Int J Cancer 1990; 46: 382-387
12. Driman DK, Kobrin MS, Kudlow JE, Asa SL. Transforming growth factor-α in normal and neoplastic human endocrine tissues. Hum Pathol 1992; 23: 1360-1365
13. Fisher DA, Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in animals. Endocrine Rev 1990; 11: 418-442
14. Marquardt H, Hunka Pillar MWH, Hood LE, Todaro GJ. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 1984; 223: 1079-1082
15. Carpenter G, Stoschek CM, Preston YA, DeLarco JE. Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. Proc Natl Acad Sci USA 1983; 80: 5627-5630
16. Masague J. Epidermal growth factor like transforming growth factor II. Interaction with epidermal growth factor receptors in the human placenta membranes and A431 cells. J Biol Chem 1983; 258: 13614-13620
17. Burgess AW. Epidermal growth factor and transforming growth factor-α. Br Med Bull 1989; 4: 401-424
18. Fujii Y, Moreira JE, Orlando C et al. Endothelin as an autocrine factor in the regulation of parathyroid cells. Proc Natl Acad Sci USA 1991; 88: 4235-4239
19. Eguchi S, Hirata Y, Imai T et al. Endothelin receptors in human parathyroid gland. Biochem Biophys Res Commun 1992; 184: 1448-1454
20. Young WS. Simultaneous use of digoxigenin and radiolabeled oligodeoxyribonucleotide probes for hybridization histochemistry. Neuropeptides 1989; 13: 271-275
21. Abbona GC, Papotti M, Gasparri G, Bussolati G. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 1995; 26: 135-138
22. Kasselberg AG, Orth DN, Gray ME, Stahlman MT. Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J Histochem Cytochem 1985; 33: 315-322
23. Aasland R, Lillehang JR, Male R, Josendak O, Verhang JE, Kleppe K. Expression of oncogenes in thyroid tumors: coexpression of c-erb B2/neu and c-erb B. Br J Cancer 1988; 57: 358-363
24. Hakim JP, Levine MA. Absence of p53 mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 1994; 78: 103-106
25. Padberg B-C, Schröder S, Jochum W et al. Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol 1995; 147: 1600-1607
26. Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995; 96: 1786-1793
27. Gogusev J, Duchambon P, Zhang P et al. Expression of Bcl-2 oncoprotein in parathyroid (PT) tissue of patients with primary (I°) and secondary (II°) hyperparathyroidism (HPTH) (Abstract). J Am Soc Nephrol 1995; 6: 961
28. Kremer R, Bolivar I, Goltzman D, Hendy GN. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989; 125: 935-941
29. Szabo A, Merke J, Beier E, Mall G, Ritz E. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1989; 35: 1045-1056
30. Fukagawa M, Fukuda N, Yi H, Kurokawa K. Resistance of parathyroid cell to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 1995; 10: 316-319